1. Nikitina T.P., Zhernyakova A.A., Ionova T.I. Priorities of quality of life research in modern health care. Quality and life. 2019; 1(21): 3-8. (in Russian)
2. Ionova T.I. Value of quality of life assessment in health care. Quality and life. 2019; 1(21): 66-70. (in Russian)
3. Laktionov K.K., Arzumanyan A.L., Bolotina L.V., Breder V.V., Buevich N.N., Danilova A.S. et al. Efficacy of nivolumab (Nivo) during 2+ line treatment and quality of life in patients with advanced refractory non-small cell lung cancer: Interim results of prospective observational study. Voprosy Onkologii. 2019; 65(1): 99-105. doi.org/10.37469/0507-3758-2019-65-1-99-105 (in Russian)
4. Ionova T.I., Kirin V.N., Sheidorova A.C., Porfirieva N.M., Nikitina T.P., Sukhonos Y.A. et al. A population study of the quality of life of the Habitancy of the Chukotka autonomous area. Ekologiya Cheloveka (Human Ecology). 2019; 2019(8): 41-49. https://doi.org/10.33396/1728-0862-8-41-49 (in Russian)
5. Salek M.S., Ionova T., Johns J.R., Oliva E.N. Appraisal of patient-reported outcome measures in analogous diseases and recommendations for use in phase II and III clinical trials of pyruvate kinase deficiency. Quality of Life Research. 2019; 28: 399-410.
6. Goswami P., Oliva E.N., Ionova T., Else R., Kell J., Fielding A.K., Jennings D.M., Karakantza M., Al-Ismail S., Lyness J., Collins G.P., McConnell S., Langton C., Al-Obaidi M.J., Oblak M., Salek S. Paper and electronic versions of HM-PRO, a novel patient-reported outcome measure for hematology: an equivalence study. J Comp Eff Res. 2019; 8(7): 523-533.
7. Goswami P., Ionova T., Oliva E.N., Else R., Kell J., Fielding A.K., Jennings D.M., Karakantza M., Al-Ismail S., Collins G.P., Lyness J., McConnell S., Langton C., Salek S. Reliability of a novel haematological malignancy specific patient-reported outcome measure: HM-PRO. Value in Health. 2020; 11(Article 571066): 9 P.
8. Tseitlin G.Ja., Kokoreva M.J., Karelin A.F., Nikitina T.P., Porfirieva N.M., Zinkovskaya A.V., Ionova T.I. Quality of life in pediatric survivors with brain tumors and in their parents after medical social rehabilitation. Bulletin of the Multinational Center for Quality of Life Research. 2019; 33-34: 7-18. (in Russian)
9. Ionova T.I., Vinogradova O.Yu., Efremova E.V., Kersilova A.Eu., Nikitina T.P., Pankrashkina M.M., Porfi rieva N.M., Poshivay A-P.A., Fominykh M.S., Shikhbabaeva D.I., Shuvayev V.A. Linguistic and cultural adaptation of Russian version of the instrument for symptom assessment in patients with myeloproliferative neoplasms - MPN10. Bulletin of the Multinational Center for Quality of Life Research. 2019; 33-34: 19-30. (in Russian)
10. Ionova T.I., Afanasiev B.V., Amdiev A.A., Andrievskikh M.I., Baryakh E.A., Vasiliev Eu.V., Volkov M.V., Volodicheva E.M., Ivanov V.V., Kaverina O.V., Kaplanov K.D., Klitochenko T.Yu., Kurakin V.I., Lazareva D.G., Larionova O.G., Lepik K.V., Lysenko I.B., Minullina R.I., Mironov O.V., Misyurina E.N., Mikhailova N.B., Mochkin N.Eu., Nikitina T.P., Osiopov Iu.S., Petrova T.S., Porfirieva N.M., Rukavitsyn O.A., Safin R.N., Simashova P.I., Smirnova E.G., Trenina N.A., Fadeeva N.V., Husainova G.N., Chang V.L., Shelekhova T.V., Sherstnev D.G. Quality of life in patients with relapsed/refractory Hodgkin lymphoma receiving treatment with brentuximab vedotin in the real world practice. Bulletin of the Multinational Center for Quality of Life Research. 2019; 33-34: 31-47. (in Russian)
11. Usoltseva E.N., Ionova T.I. Quality of life peculiarities in women during postmenopause period. Bulletin of the Multinational Center for Quality of Life Research. 2019; 33-34: 55-67. (in Russian)
12. Laktionov K.K., Breder V.V., Arzumanyan A.L. et al. Quality of life, symptoms and clinical efficacy of nivolumab (Opdivo) as second or subsequent line therapy in patients with advanced refractory non-small cell lung cancer: a prospective observational study. Russian Multicenter Observation Program Results Brochure supported by Bristol-Myers Squibb. 2019; 19 p. (in Russian)
13. Orlova R., Laktionov K., Bolotina L., Breder V., Danilova A., Filippova E., Kornietskaya A., Kramchaninov M., Kushniruk Eu., Latipova D., Ledin Eu., Mochalova A., Moiseenko F., Nikitina T., Orlov S., Protsenko S., Sarantseva K., Stroyakovskiy D., Zinkovskaya A., Ionova T. Multicenter observational prospective study of nivolumab (Nivo) as 2+ line treatment in advanced refractory NSCLC pts: Clinical and quality of life outcomes. J Clin Oncol 37, 2019 (suppl; abstr e20567).
14. Zhernyakova A., Aleksanian L., Ionova T., Kostroma I., Nikitina T., Porfir'eva N., Rybakova L., Zapreeva I., Gritsaev S. Symptom burden and oxidative stress in multiple myeloma patients in early post-transplantation period. Hemasphere. 2019; 3(S1): 957.
15. Nikitina T., Bykova A., Chelysheva E., Ionova T., Nemchenko I., Petrova A., Porfir'eva N., Ionova T., Shukhov O., Tsyba N., Turkina A. Quality of life in chronic myeloid leukemia patients with deep molecular response after stopping treatment by tyrosine kinase inhibitors at long-term follow-up. Hemasphere. 2019; 3(S1): 879.
16. Lepik K. V., Mikhailova N. B., Kondakova E. V., Tsvetkova L. A., Zalyalov Yu. R., Borzenkova E. S., Moiseev I. S., Baykov V. V., Nikitina T.P., Porfir'eva N.M., Ionova T.I., Afanasyev B. V. Nivolumab for treatment of patients with relapsed/refractory classical Hodgkin's lymphoma (cHL): clinical and patient-reported outcomes. Hemasphere. 2019; S1: 564.
17. Goswami P., Ionova T., Oliva E.N., Else R., Kell J., Fielding A.K., Jennings D.M., Karakantza M., Al-Ismail S., Collins G.P., Mcconnell S., Langton C., Salek S. Minimal clinically important difference and responsiveness for HM-PRO in patients with haematological malignancies. Hemasphere. 2019; (S1): 315.
18. Petrova A., Chelysheva E., Shukhov O., Bykova A., Nemchenko I., Gusarova G., Tsyba N., Ionova T., Turkina A. Withdrawal syndrome after tyrosine kinase inhibitors discontinuation in patients with chronic myeloid leukemia and deep molecular response in a multicenter prospective study (RU-SKI). Hemasphere. 2019; S1: 876.
19. Oliva E., Cufari P., Andriani A., Stelitano C., Frongia S., Alati C., Martini V., Gangemi D., Roda F., Montechiarello E., Greve B., Pratico G., Salek S., Ionova T., Martino B. Assessment of HM-PRO Italian version in patients with haematological malignancies in clinical practice. Hemasphere. 2019; S1: 693.
20. Lepik K. V., Mikhailova N. B., Kondakova E. V., Tsvetkova L. A., Zalyalov Yu. R., Borzenkova E. S., Moiseev I. S., Baykov V. V., Nikitina T.P., Porfir'eva N.M., Ionova T.I., Afanasyev B. V. Response to Nivolumab as >3rd line therapy in pts with relapsed/refractory classical Hodgkin's lymphoma (cHL) and its impact on quality of life in responders and nonresponders. Hematological Oncology. 2019; Vol. 37(2): 495.
21. Nikitina T., Ionova T., Kirin V.N., Sheidorova A.S., Porfi'eva N., Sukhonos Yu.A. Quality of life (QoL) in Arctic regions: QoL population norms in Chukotka. Quality of Life Research. 2019; 28(1): 105.
22. Tseytlin G., Guseva M., Rumyantsev A., Karelin A., Borodina I., Nikitina T., Ionova T. Socio-demographic and medico-social factors affecting the quality of life of surviving children with brain tumors, acute lymphoblastic leukemia and their parents. Journal of Psychosocial Oncology Research and Practice. 2019; 1: 120.
23. Ionova T., Nikitina T., Porfirieva N., Petrova A., Chelysheva E.Yu., Shukhov O.A., Bykova A., Gusarova G., Nemchenko I., Tsyba N., Turkina A. The impact of comorbidity on quality of life in chronic myeloid leukemia patients with deep molecular response who stopped therapy by tyrosine kinase inhibitors: results of the RU-SKI Trial. Blood. 2019; 134(1): 2925.
24. Ionova T.I. , Afanasiev B.V., Andrievskih M.I., Amdiev A.A., Baryakh E.A., Chang V.L Husainova G.N., Ivanov V.V., Kaplanov K.D., Kaverina O.V., Klitochenko T.Yu., Kurakin V.I., Larionova O.G., Lazareva D.G., Lepik K.V., Lysenko I.B., Mikhailova N.B., Minullina R.I., Mironov O.V., Misyurina E.N., Mochkin N.Eu., Nikitina T.P., Osipov Iu.S., Petrova T.S., Porfir'eva N.M., Rykavitcin O.A., Safin R.N., Shelekhova T.V., Sherstnev D.G., Simashova P.I., Smirnova E.G., Trenina N.A., Vasiliev Eu.V., Volkov M.V., Volodicheva E.M. Response to brentuximab vedotin and quality of life in patients with relapsed/refractory Hodgkin lymphoma (RR HL) in the real world setting. Blood. 2019; 134(1): 5296.
25. Pemberton-Whiteley Z., Oliva E.N., Geissler J., Wintrich S., Salek S., Ionova T., Tate A.R., Bradley J. Identifying Differences in the Quality of Life of Patients with Acute Leukemia: A Global Survey. Blood. 2019; 134(1): 4785.
26. Goswami P., Ionova T., Oliva E.N., Else R., Kell J., Fielding A.K., Jennings D., Karakantza M., Al-Ismail S., Collins G. P., McConnell S., Langton C., Salek S.. Final Development of the First Generic Quality of Life and Symptoms Measure Specific for Hematological Malignancies: The HM-PRO. Blood. 2019; 134(1): 3484.
27. Ionova T.I, Afanasiev B.V, Amdiev A.A., Andrievskih M.I., Baryakh E.A., Vasiliev Eu.V., Volkov M.V., Volodicheva E.M., Ivanov V.V., Kaverina O.V., Kaplanov K.D., Kiseleva M.Ya., Klitochenko T.Yu., Kurakin V.I., Lazareva D.G., Larionova O.G., Lepik K.V., Lysenko I.B., Minullina R.I., Mironov O.V., Misyurina E.N., Mikhailova N.B., Mochkin N.Eu., Nikitina T.P., Osipov Iu.S., Petrova T.S., Porfirieva N.M., Rykavitcin O.A., Safin R.N., Simashova P.I., Smirnova E.G., Trenina N.A., Fadeeva N.V., Husainova G.N., Chang V.L, Shelekhova T.V., Sherstnev D.G. Quality of life and clinical response to brentuximab vedotin in patients with relapsed/refractory Hodgkin lymphoma (RR HL) in the real world setting. Vol. 8, Cellular Therapy and Transplantation. 2019. 8 (3): 53-54.
28. Volkova A.G., Chernenko O.A., Pareeva Yu.I., Kasavtsova E.A., Ionova T.I., Nikitina T.P., Paina O.V., Gevorgyan A.G., Bykova T .A., Osipova A.A., Semyonova E.V., Potapchuk A.A., Zubarovskaya L.S., Afanasiev B.V. Social rehabilitation and its impact on the quality of life in children with oncohematological diseases. Russian Journal of Pediatric Hematology and Oncology. Collection of materials of the X Congress, "Actual Problems and Prospects for the Development of Pediatric Oncology and Hematology in the Russian Federation." 2019; 6(S1): 135. (in Russian)

© Создание сайтов

Последнее обновление (last update): 19-04-2024